Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Wearable cyborg training linked to longer walking distances in people with ALS (opens in a new tab)

medicalxpress.com · 2026-10-14

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

One claim goes further than the study.

  • 3 supported
  • 1 overstated

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly supported

One claim overstates the study. Three of four check out.

  • 3 supported
  • 1 overstated
Open claim evidence
3

The source study

Impact of hybrid assistive limb on gait ability and quality of life in patients with amyotrophic lateral sclerosis

Frontiers in Neurology · 2026
Open source record (opens in a new tab)
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

  • The study this story reportspresented as the new finding

    Impact of hybrid assistive limb on gait ability and quality of life in patients with amyotrophic lateral sclerosis

    Frontiers in Neurology · 2026

    Publisher (opens in a new tab)
  • The study this story reportspresented as the new finding

    Impact of hybrid assistive limb on gait ability and quality of life in patients with amyotrophic lateral sclerosis

    Publisher (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4OverstatedAfter one course of HAL-assisted treatment, participants walked nearly 12 meters farther in a two-minute walking test.View evidenceHide evidence

As statednearly 12 meters (39 feet) farther

Why this verdict

The reported magnitude is supported: 2MWT distance increased from 92.27 m to 104.16 m, a mean change of about 11.89 m, after one course. However, the claim is framed as a causal treatment effect, while the paper profile describes a single-arm pre–post design without a concurrent control group, so causal attribution to HAL is stronger than the abstract-level evidence can establish.

1

Study evidence

After one course of HAL gait training, 2MWT distance improved from 92.27 m (SD 40.46) to 104.16 m (SD 41.73) (p < 0.001).Mean change +11.89 m (baseline 92.27 [40.46] → 104.16 [41.73]); p < 0.001

“This study aimed to evaluate the effects of HAL treatment on gait ability and quality of life (QoL) in patients with amyotrophic lateral sclerosis (ALS).”
Claim 2 of 4SupportedA new study from Toho University in Japan examined walking performance and quality of life in 30 patients with ALS who underwent training with the Hybrid Assistive Limb (HAL).View evidenceHide evidence

As stated30 patients

Why this verdict

The abstract-level profile supports that 30 ALS patients completed one course of HAL gait training and that the study evaluated gait performance and QoL/SF-36 outcomes. The supplied profile does not independently verify the Toho University/Japan affiliation, but the scientific content of the claim is supported at this depth.

1

Study evidence

After one course of HAL gait training, 2MWT distance improved from 92.27 m (SD 40.46) to 104.16 m (SD 41.73) (p < 0.001).Mean change +11.89 m (baseline 92.27 [40.46] → 104.16 [41.73]); p < 0.001

“This study aimed to evaluate the effects of HAL treatment on gait ability and quality of life (QoL) in patients with amyotrophic lateral sclerosis (ALS).”
2

Study evidence

No significant change in quality of life (SF-36) was observed after one course of HAL treatment in this cohort.

“QoL was evaluated using the 36-Item Short Form Health Survey.”
Claim 3 of 4SupportedQuality-of-life scores remained largely stable after treatment, with no statistically significant change in the main SF-36 component scores.View evidenceHide evidence

Why this verdict

The abstract-level profile reports SF-36 QoL assessment and states that there were no significant changes in QoL before versus after one course of HAL treatment. The profile does not provide full post-treatment SF-36 component statistics, but the story’s main point that QoL remained largely stable with no significant main SF-36 change is consistent with the abstract.

1

Study evidence

No significant change in quality of life (SF-36) was observed after one course of HAL treatment in this cohort.

“QoL was evaluated using the 36-Item Short Form Health Survey.”
Claim 4 of 4SupportedThe article says the study did not include a control group, so it cannot establish that HAL alone caused the increase in walking distance, and larger controlled studies are needed.View evidenceHide evidence

Why this verdict

The paper profile identifies the study as single-arm pre–post and lists lack of a randomized or concurrent control group as a limitation that restricts causal inference. The story’s statement that HAL alone cannot be established as the cause, and that larger controlled studies are needed, accurately reflects the interpretation-changing limitation.

1

Study evidence

After one course of HAL gait training, 2MWT distance improved from 92.27 m (SD 40.46) to 104.16 m (SD 41.73) (p < 0.001).Mean change +11.89 m (baseline 92.27 [40.46] → 104.16 [41.73]); p < 0.001

“This study aimed to evaluate the effects of HAL treatment on gait ability and quality of life (QoL) in patients with amyotrophic lateral sclerosis (ALS).”
2

Study evidence

No significant change in quality of life (SF-36) was observed after one course of HAL treatment in this cohort.

“QoL was evaluated using the 36-Item Short Form Health Survey.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Intervention details: nine HAL sessions lasting 20–40 minutes each, over at least 4 weeks.

    The story mentions one course of HAL treatment but, based on the supplied presentation, does not include the session number, duration, or minimum treatment period.

    From single-arm pre–post; Single-arm pre–post

  • Gait testing was performed without HAL assistance.

    The paper profile specifies that gait tests were performed without HAL assistance. The supplied story presentation does not indicate this, which is relevant because it clarifies that the measured change was not simply walking while wearing the assistive device.

    From single-arm pre–post

  • Population/generalizability limitation: participants were ALS patients with unsteady gait who could walk at least 10 m with assistance.

    The story identifies the participants as ALS patients but does not mention the ambulatory eligibility criterion, which may limit generalizability to less ambulatory ALS patients.

    From single-arm pre–post; Single-arm pre–post

  • Reporting limitation: the abstract does not provide full QoL post-treatment statistics or detailed numeric results for all gait parameters such as 10-meter walk speed, step length, and cadence.

    The story focuses on the 2MWT and overall SF-36 non-significance and does not discuss the limited abstract-level reporting for other measured gait parameters or detailed QoL statistics.

    From single-arm pre–post; Single-arm pre–post

5 things the story did carry across
  • Study design: single-arm within-subject pre–post evaluation of one HAL gait-training course in ALS patients.
  • Gait outcome: 2-minute walk distance improved by about 11.89 m after one course, from 92.27 m to 104.16 m, p < 0.001.
  • QoL outcome: SF-36 quality-of-life measures showed no significant pre–post change after one course.
  • Major causal-inference limitation: no randomized or concurrent control group.
  • Short-term follow-up only: outcomes were assessed after one course, and durability beyond the course was not reported.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEvaluate whether a course of Hybrid Assistive Limb (HAL) gait training improves gait ability in patients with amyotrophic lateral sclerosis (ALS), assessed without HAL assistance.single-arm pre–postExpand

In plain English

Single-arm pre–post study in 30 patients with ALS and unsteady gait who could walk ≥10 m with assistance; after one course of nine HAL sessions (20–40 min each, over ≥4 weeks) gait was assessed without the device. The 2-minute walk distance improved from 92.27 m (40.46) to 104.16 m (41.73) (p < 0.001). No significant changes in quality-of-life measures were reported after one course.

Key findings

  • After one course of HAL gait training, 2MWT distance improved from 92.27 m (SD 40.46) to 104.16 m (SD 41.73) (p < 0.001).Mean change +11.89 m (baseline 92.27 [40.46] → 104.16 [41.73]); p < 0.001
  • No significant changes in quality-of-life measures were observed after one course; baseline mental component summary score was 55.35 (SD 8.27).
“This study aimed to evaluate the effects of HAL treatment on gait ability and quality of life (QoL) in patients with amyotrophic lateral sclerosis (ALS).”
What this piece can’t prove
  • Single-arm pre–post design without a randomized or concurrent control group limits causal inference.
  • Sample size for completers reported as 30; abstract does not provide information on screening, exclusions, or attrition.
  • Abstract does not present detailed pre–post results for the 10-m walk test parameters (speed, step length, cadence), limiting assessment of gait quality changes beyond 2MWT distance.
  • Participants were selected as able to walk ≥10 m with assistance, which may limit generalizability to less ambulatory ALS patients.

1 further detail could not be confirmed from the summary.

2human in vivoEvaluate whether a course of HAL treatment changes quality of life (QoL) in patients with ALS (SF-36).Single-arm pre–postExpand

In plain English

Single-arm pre–post evaluation in 30 ALS patients who completed one course of nine HAL gait-training sessions (20–40 min each) over ≥4 weeks. Quality of life was measured with the 36-Item Short Form Health Survey (SF-36); the mental component summary score was 55.35 (8.27) at baseline. The authors report no significant changes in QoL after one course of HAL treatment.

Key findings

  • No significant change in quality of life (SF-36) was observed after one course of HAL treatment in this cohort.
“QoL was evaluated using the 36-Item Short Form Health Survey.”
What this piece can’t prove
  • Abstract provides baseline mental component mean but does not provide post-treatment SF-36 summary statistics or p-values for QoL.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Impact of hybrid assistive limb on gait ability and quality of life in patients with amyotrophic lateral sclerosis

Frontiers in Neurology · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 36 candidate papers

Selected

Impact of hybrid assistive limb on gait ability and quality of life in patients with amyotrophic lateral sclerosis

Frontiers in Neurology · 2026 · Crossref

Source (opens in a new tab)

And 30 more candidates considered.